SCHEMBL2643718

SCHEMBL2643718

COc1ccc(CN2C(=O)c3ccccc3C2CCC(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
KDM4E B2RXH2 1/20 0.49
HKDC1 Q2TB90 1/20 0.49
FFAR1 O14842 1/20 0.48
GAA P10253 2/20 0.47
CASP3 P42574 2/20 0.47
APAF1 O14727 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
POLB P06746 1/20 0.45
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.44
MDM2 Q00987 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2643804 0.88 MEN1 (0.51) MEN1KMT2AKDM4EHKDC1FFAR1
SCHEMBL30296312 0.88 MEN1 (0.51) MEN1KMT2AKDM4EHKDC1FFAR1
SCHEMBL2645468 0.88 MEN1 (0.51) MEN1KMT2AGAAALDH1A1LMNA
SCHEMBL2643782 0.87 KDM4E (0.52) MEN1KMT2AKDM4EHKDC1FFAR1
SCHEMBL2644660 0.85 KDM4E (0.53) MEN1KMT2AKDM4EHKDC1FFAR1
SCHEMBL2644438 0.85 MAPT (0.54) MEN1KMT2AKDM4ECASP3MAPT
SCHEMBL2643348 0.84 KDM4E (0.54) MEN1KMT2AKDM4EHKDC1FFAR1
SCHEMBL30296402 0.84 KDM4E (0.51) MEN1KMT2AKDM4EHKDC1FFAR1
SCHEMBL26095977 0.84 KDM4E (0.51) MEN1KMT2AKDM4EHKDC1FFAR1
SCHEMBL2644659 0.83 FFAR1 (0.55) MEN1KMT2AKDM4EHKDC1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796313-B2 Substituted dihydroisoindolones as allosteric modulators of glucokinase JANSSEN PHARMACEUTICA N.V. (BE) 2014-08-05 US disclosed
CN-101316836-A Substituted dihydroisoindolones as allosteric modulators of glucokinase JANSSEN PHARMACEUTICA NV (BE) 2008-12-03 CN disclosed
US-20070099930-A1 Substituted Dihydroisoindolones As Allosteric Modulators of Glucokinase JANSSEN PHARMACEUTICA N.V. (BE) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099930-A1 Substituted Dihydroisoindolones As Allosteric Modulators of Glucokinase GCK, GCKR, GPR119 MEN1 4234/4885KMT2A 2178/4885KDM4E 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.